PRESS RELEASE
For Immediate Release
Key Organics Ltd., Change of Ownership & Control
CAMELFORD, Cornwall, England. Contract Research (CRO) provider Key Organics Ltd. wishes to announce its change of ownership through a management buyout (MBO) completed on Wednesday 5th February 2025. Dr Joe Carey, Managing Director of Key Organics Ltd., and family have acquired the entire shareholding through their holding company, FioCap Ltd.
Key Organics is a leading provider of contract research and development services to the international life sciences industries and owner of “Bionet”, a proprietary collection of over 330,000 complex research intermediates, fragments (for fragment-based drug discovery), screening compounds and biochemicals. The ability to integrate these two offerings has been a differentiator and enabler for the business to attract new customers and achieve growth.
Dr Joe Carey, Managing Director of Key Organics Ltd., commenting on this MBO announcement:
“Through the mentorship and stewardship within the Tennants Consolidated Ltd. (TCL) Group over the last 22 years, Key Organics has grown to establish itself as a serious player within the Chemistry CRO sector. Together with a $1M investment in a state-of-the-art process development lab in 2023/4 as well as achieving ISO9001 quality accreditation in January 2025 we are well placed to further grow the business as a stand-alone SME and realise our full potential within a challenging and competitive global market environment. I am personally very grateful to our board and to TCL for this opportunity as well as their incredible and unwavering support during the 13 years we have worked together”.
Sean Sloan, Chief Financial Officer of Tennants Consolidated Ltd, and former Chair of Key Organics Limited, commenting on the MBO announcement:
“This successful MBO, led by Dr. Joe Carey, is a testament to the hard work, dedication, and innovation that has been fostered under our stewardship. Over the years, Key Organics has consistently demonstrated excellence in providing cutting-edge solutions to the life sciences sector.
We are confident that this new chapter will allow Key Organics to further capitalize on its strengths. While this marks the end of our direct ownership, we look forward to seeing the company thrive. On behalf of TCL, I would like to express our gratitude to the entire Key Organics team for their contributions and wish them continued success in their next chapter”.
